Head-to-head comparison of leading blood tests for Alzheimer's disease pathology.

Differences in median plasma Aβ42/Aβ40 levels were much smaller in magnitude, ranging from 13% to 10% lower in the amyloid PET positive group, but were still highly significant due to low variance in values.

also in 132,142 other papers